SEASONAL VARIATIONS OF eGFR AND PATIENT PROGNOSIS

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
SEASONAL VARIATIONS OF eGFR AND PATIENT PROGNOSIS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Akihiko
Koshino
Akihiko Koshino koshino1307@gmail.com Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan *
Megumi Oshima mgm_oshima@yahoo.co.jp Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
Yuta Yamamura yuta.yamamura@gmail.com Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
Ryo Nishioka rryo125@gmail.com Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
Satoshi Hara satoshy57@hotmail.com Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
Kiyoaki Ito kiyokiyo1980fukui@yahoo.co.jp Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
Ichiro Mizushima ichiro7753@yahoo.co.jp Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
Akinori Hara hara-akinori@med.kanazawa-u.ac.jp Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
Norihiko Sakai norin0826@yahoo.co.jp Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
Miho Shimizu mshimizu@staff.kanazawa-u.ac.jp Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
Takashi Wada twada@staff.kanazawa-u.ac.jp Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
Yasunori Iwata iwatay@staff.kanazawa-u.ac.jp Kanazawa University Department of Nephrology and Rheumatology Ishikawa Japan -
-
-
-

Heat exposure associated with climate change has been implicated in recurrent, asymptomatic acute kidney injury, increasing the risk of CKD progression and mortality. However, the relationship between seasonal variation in estimated glomerular filtration rate (eGFR) and clinical outcomes in routine outpatient care in Japan remains unclear. This study aimed to describe seasonal changes in eGFR and to assess the prognostic impact of summer eGFR decline on renal replacement therapy (RRT) initiation and cardiovascular outcomes in regular outpatient settings.

We conducted a retrospective cohort study of adult outpatients who underwent serum creatinine measurement between 2010 and 2023. Seasons were defined by average temperatures in Kanazawa city, Ishikawa, Japan: spring (March–June), summer (July–August), autumn (September–November), and winter (December–February). Seasonal differences in eGFR were estimated using linear mixed-effects models, with spring as the reference. We defined “a summer eGFR decline” as ≥3.0 mL/min/1.73m² from spring to summer in the same year since this value was close to the upper threshold of the lowest quartile. Associations between summer eGFR decline and subsequent RRT initiation, cardiovascular events, heart failure hospitalization, and all-cause mortality (≥30 days) were analyzed using multivariable time-dependent Cox proportional hazards models with multiple imputation for missing data.

Among 10,773 patients (46% female, mean age 53±20 years, mean eGFR 85.2±29.6 mL/min/1.73m²), eGFR significantly decreased in summer (-1.2 [95% CI -1.3 to -1.1]) and increased in winter (+0.8 [95% CI 0.7 to 0.9]) compared with spring (both p<0.01). The median spring–summer eGFR change was -1.2 (IQR -3.2 to 1.1). Patients with summer eGFR decline were older and more likely to have higher baseline eGFR, hypertension, and diabetes. Summer eGFR decline was associated with increased risks of RRT initiation (HR 4.5 [95% CI 2.9–6.8], p<0.001) and heart failure hospitalization (HR 1.8 [95% CI 1.1–3.1], p=0.02), but not cardiovascular events or mortality (p≥0.06).

In routine outpatient practice, eGFR shows seasonal variation, with summer decline associated with higher risks of RRT initiation and heart failure hospitalization. These findings suggest the potential value of early intervention strategies considering seasonal kidney function changes.

Kewords